FDA Panel To Continue Review of Genetically Modified Salmon
[img_assist|nid=194824|title=|desc=|link=none|align=left|width=150|height=145]Sep. 21, 2010 (GreenAnswers) – The FDA panel tasked with reviewing a request to permit genetically modified salmon to be sold in the U.S. decided on Monday to not vote on the matter. ABC News reports that several members of the panel were concerned that there was not enough data presented to allow a determination to be made regarding the safety of genetically modified salmon.
Ron Stotish, the CEO of AquaBounty Technologies, indicated that the panel was confused by the large amount of information presented during the eight hour hearing.
The non-decision is a temporary setback for AquaBounty Technologies, which is hoping to introduce a salmon egg which includes a growth hormone gene that causes salmon to grow twice as quickly.
Opponents have argued that the potential health and environmental effects are too great to permit genetically modified salmon to be produced and consumed.